2002 (12) TMI 422

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... ember (T)]. The present appellant M/s. White-Way Products, Vadodara is the manufacturer of pharmaceutical products. They have their own factory and manufacture pharmaceutical products therein. M/s. AIMCO Pharmaceutical Manufacturing Co. is a loan licencee. They have no factory of their own. They produce certain pharmaceutical products in the factory of M/s. White-Way Products. Duty demand of .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... ent appellate authority to take a view that, to be eligible for the exemption, a manufacturer has to have his own unit, inasmuch as such a view would not be in conformity with the dictum contained in the judgment in the case of M/s. Indica Laboratories. The second contention is that the impugned proceedings are in terms of remand Order No. CS-64/BRD/95, dated 18th July, 1995 of Commissioner (Appea .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X

..... ntral Excise law. 4. The dispute as to whether a loan licencee is entitled to small scale exemption under Central Excise law had come up before the Gujarat High Court for decision in the context of exemption under Notification No. 175/86, dated 1-3-86. The present Notification 1/93 is successor to Notification No. 175/86. After considering the legal position of loan licencees under the Drugs and .....

X X   X X   Extracts   X X   X X

→ Full Text of the Document

X X   X X   Extracts   X X   X X